Options to change Medicare payment for outpatient prescription drugs and biotechnology products

The debates over the Obama Administration’s health care reform law, and, more recently, the federal budget deficit and national debt have focused attention on the growth in costs of the Medicare program.  Three approaches to reducing Medicare expend…


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!